These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2033454)
1. Prevention of cerebral vasospasm by actinomycin D. Shigeno T; Mima T; Yanagisawa M; Saito A; Goto K; Yamashita K; Takenouchi T; Matsuura N; Yamasaki Y; Yamada K J Neurosurg; 1991 Jun; 74(6):940-3. PubMed ID: 2033454 [TBL] [Abstract][Full Text] [Related]
2. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177 [TBL] [Abstract][Full Text] [Related]
3. The role of endothelin in experimental cerebral vasospasm. Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695 [TBL] [Abstract][Full Text] [Related]
4. Possible role of endothelin in the pathogenesis of cerebral vasospasm. Shigeno T; Mima T; Yanagisawa M; Saito A; Fujimori A; Shiba R; Goto K; Kimura S; Yamashita K; Yamasaki Y J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S480-3. PubMed ID: 1725419 [TBL] [Abstract][Full Text] [Related]
5. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm. Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224 [TBL] [Abstract][Full Text] [Related]
6. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerebral vasospasm after subarachnoid hemorrhage. Mima T; Mostafa MG; Mori K Acta Neurochir Suppl; 1997; 70():65-7. PubMed ID: 9416280 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203]. Zimmermann M; Seifert V Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274 [TBL] [Abstract][Full Text] [Related]
9. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. Kwan AL; Bavbek M; Jeng AY; Maniara W; Toyoda T; Lappe RW; Kassell NF; Lee KS J Neurosurg; 1997 Aug; 87(2):281-6. PubMed ID: 9254094 [TBL] [Abstract][Full Text] [Related]
10. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732 [TBL] [Abstract][Full Text] [Related]
11. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. Zhou C; Yamaguchi M; Kusaka G; Schonholz C; Nanda A; Zhang JH J Cereb Blood Flow Metab; 2004 Apr; 24(4):419-31. PubMed ID: 15087711 [TBL] [Abstract][Full Text] [Related]
12. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959 [TBL] [Abstract][Full Text] [Related]
13. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. Cosentino F; McMahon EG; Carter JS; Katusić ZS J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S332-5. PubMed ID: 7509979 [TBL] [Abstract][Full Text] [Related]
14. Alterations in endothelium-dependent responsiveness of the canine basilar artery subarachnoid hemorrhage. Kim P; Sundt TM; Vanhoutte PM J Neurosurg; 1988 Aug; 69(2):239-46. PubMed ID: 3134520 [TBL] [Abstract][Full Text] [Related]
15. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats. Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720 [TBL] [Abstract][Full Text] [Related]
16. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm. Cirak B; Kiymaz N; Ari HH; Ugras S Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650 [TBL] [Abstract][Full Text] [Related]
17. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Matsumura Y; Ikegawa R; Suzuki Y; Takaoka M; Uchida T; Kido H; Shinyama H; Hayashi K; Watanabe M; Morimoto S Life Sci; 1991; 49(11):841-8. PubMed ID: 1875792 [TBL] [Abstract][Full Text] [Related]
18. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581. Sasaki T; Wakai S; Asano T; Takakura K; Sano K J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009 [TBL] [Abstract][Full Text] [Related]
19. Effect of endothelin on the canine basilar artery. Kobayashi H; Hayashi M; Kobayashi S; Kabuto M; Handa Y; Kawano H Neurosurgery; 1990 Sep; 27(3):357-61. PubMed ID: 2234327 [TBL] [Abstract][Full Text] [Related]
20. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. Itoh S; Sasaki T; Asai A; Kuchino Y J Neurosurg; 1994 Nov; 81(5):759-64. PubMed ID: 7931624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]